Diseases & Disorders
(G800)
IRS Verified
DX Registered
990 on File
BREAKTHROUGH T1D
Financial strength (30%)
77/100
Reliability (20%)
70/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$301.7M
Total Revenue
$281.0M
Total Expenses
$350.6M
Net Assets
688
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.9%
Fundraising Efficiency
167.5%
Operating Reserve
14.97x
Liability-to-Asset
34.4%
Revenue Diversification
91.8%
Executive Compensation
$4.7M
Compared with Peers
FY 2025
Compared with 15 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
74.9% | 83.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.1% | 8.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
18.0% | 10.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
167.5% | 567.2% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
15.0 mo | 9.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
34.4% | 29.1% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.8% | 91.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
16.9% | 5.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
21.1% | 4.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
6.9% | 0.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $301.7M | $281.0M | $350.6M | 74.9% | 688 |
| 2024 | $258.1M | $232.1M | $331.1M | 74.4% | 632 |
| 2023 | $223.8M | $215.8M | $307.2M | 77.3% | 570 |
| 2022 | $238.6M | $162.9M | $294.9M | 75.2% | 496 |
| 2021 | $223.0M | $115.5M | N/A | — | 748 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.